1. COMBINATION OF TGR‐1202, UBLITUXIMAB, AND BENDAMUSTINE IS SAFE AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED DLBCL AND FOLLICULAR LYMPHOMA. (June 2017) Authors: Lunning, M.A.; Vose, J.M.; Bierman, P.J.; Bociek, G.; Schreeder, M.T.; Siddiqi, T.; Blumel, S.M.; Cutter, K.; Pauli, E.K.; Bui, D.; Sportelli, P.; Miskin, H.P.; Purdom, M.; Weiss, M.S.; Fowler, N.H. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗